Important Notice to Shareholders of Applied Therapeutics, Inc. from The Gross Law Firm
NEW YORK, Feb. 03, 2025
The Gross Law Firm notifies shareholders of Applied Therapeutics, Inc. (APLT) that a securities class action lawsuit has been filed against the Company. The lawsuit alleges that Applied Therapeutics and certain of its executives violated federal securities laws by making false and misleading statements concerning the Company’s business, operations, and financial condition.
Background
According to the complaint, during the relevant period, the defendants made false and misleading statements regarding the Company’s financial results, clinical trials, and regulatory approvals. Specifically, the defendants allegedly misrepresented the progress of the Company’s lead drug candidate, AT-001, which is being developed for the treatment of a rare genetic disorder.
Impact on Individual Shareholders
The filing of this lawsuit may negatively impact the market price of Applied Therapeutics’ common stock. Shareholders who purchased or otherwise acquired Applied Therapeutics securities during the class period may be able to recover their losses through the lawsuit.
Impact on the World
The consequences of this lawsuit extend beyond Applied Therapeutics and its shareholders. The pharmaceutical industry as a whole may face increased scrutiny from regulators and investors in the wake of this development. The lawsuit highlights the importance of transparency and accuracy in reporting clinical trial data and financial results.
Class Action Lawsuit Details
The class action lawsuit was filed in the United States District Court for the Southern District of New York. The lead plaintiff is the City of Sterling Heights Police and Fire Retirement System. The case is captioned City of Sterling Heights Police and Fire Retirement System v. Applied Therapeutics, Inc. et al., Case No. 1:25-cv-00565.
Next Steps for Shareholders
Shareholders who purchased or otherwise acquired Applied Therapeutics securities during the class period and wish to join the class action lawsuit should contact The Gross Law Firm as soon as possible. Shareholders may also contact the court directly to inquire about the status of the case.
Conclusion
The Gross Law Firm encourages shareholders of Applied Therapeutics to remain vigilant regarding any developments in this case. The filing of this securities class action lawsuit underscores the importance of accurate and transparent reporting in the pharmaceutical industry. Shareholders who believe they may be affected by this lawsuit are encouraged to contact The Gross Law Firm for a free consultation.
- Applied Therapeutics, Inc. (APLT)
- Securities class action lawsuit
- False and misleading statements
- Clinical trials
- Regulatory approvals
- Pharmaceutical industry
- Transparency and accuracy
